Marizyme Inc (MARZ) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access MARZ Annual Balance Sheets →
Observing balance sheet movements over recent quarters helps explain how Marizyme Inc adapts its asset base and funding mix.
Quarterly Report, GAAP in USD millions
ITEM
(Sep 30 2024)
(Jun 30 2024) (Mar 31 2024) (Dec 31 2023) (Sep 30 2023)
Assets
Cash & cash equivalent0.06
Deposit Assets0.03
Cash & Short-term Investments0.00
Accounts receivable0.04
Inventories0.03
Other Current Assets0.00
Prepaid Expense, Current AS0.73
Total Current Assets0.88
Equipment/Property/Plant Net0.00
Goodwill net5.42
Intangible Assets14.04
Prepaid Expense, Noncurrent, Total PR0.12
Other Assets, Noncurrent0.80
Operating Lease Right Of Use Asset0.80
Total Assets21.26
Liabilities
Accounts Payable and Accrued Liabilities, Current LI3.37
Derivative Liability, Current DE0.00
Notes Payable, Current NO2.74
Other Liabilities, Current23.87
Total Current Liabilities29.98
Convertible Debt, Noncurrent LO0.00
Total Long-term Debt0.00
Other liabilities, Noncurrent6.82
Operating Lease Liability Current0.44
Operating Lease Liability Noncurrent0.36
Contingent Liabilities-
Total Liabilities36.80
Stockholders' Equity
Common Stock Value0.13
Additional Paid In Capital Common Stock154.65
Retained Earnings / Accumulated Deficit-170.32
Other Equity0.00
Common Stockholder's Equity-15.54
Total Stockholder's Equity-15.54
Liabilities & Stockholder's Equity21.26
4 historic quarters locked

Sign in to unlock the full Marizyme Inc balance sheet history.

About Marizyme Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-Q (Period: 20240930)
  • Filed with the SEC: March 5, 2025
  • Source: form10-q.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001493152-25-009226

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.